Moleculin Biotech, Inc. SEC filings MBRX

Moleculin Biotech, Inc. has 838 filings in SEC EDGAR's recent list, going back to Dec 4, 2015. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Moleculin Biotech, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Nov 4, 2026 Nov 4, 2026
8-K Current report
Regulation FD disclosure
Oct 30, 2026 Oct 30, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Oct 20, 2026 Oct 16, 2026
8-K Current report
Regulation FD disclosure
Oct 16, 2026 Oct 16, 2026
S-8 Employee stock plan registration Oct 15, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Oct 9, 2026 Oct 9, 2026
8-K Current report
Regulation FD disclosure
Oct 5, 2026 Oct 5, 2026
8-K Current report
Regulation FD disclosure
Sep 29, 2026 Sep 29, 2026
8-K Current report
Regulation FD disclosure
Sep 28, 2026 Sep 28, 2026
8-K Current report
Regulation FD disclosure
Sep 25, 2026 Sep 25, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 23, 2026 Sep 23, 2026
8-K Current report
Listing notice
Sep 18, 2026 Sep 15, 2026
8-K Current report
Regulation FD disclosure
Sep 14, 2026 Sep 14, 2026
8-K Current report
Regulation FD disclosure
Aug 31, 2026 Aug 31, 2026
DEFA14A Additional proxy material Aug 24, 2026 —
DEF 14A Proxy statement Aug 24, 2026 Oct 9, 2026
424B5 Prospectus supplement Aug 21, 2026 —
PRE 14A Preliminary proxy statement Aug 14, 2026 Oct 9, 2026
8-K Current report
Results of operations
Aug 14, 2026 Aug 14, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Material agreement
Aug 3, 2026 Jul 31, 2026
424B5 Prospectus supplement Aug 3, 2026 —
EFFECT Filing Jul 31, 2026 —
8-K Current report
Regulation FD disclosure
Jul 31, 2026 Jul 31, 2026
S-1/A Amended registration statement Jul 31, 2026 —
S-1/A Amended registration statement Jul 30, 2026 —
S-1 Registration statement Jul 29, 2026 —
DRS Filing Jul 15, 2026 —
8-K Current report
Regulation FD disclosure
Jun 30, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Jun 30, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Jun 5, 2026 Jun 5, 2026
8-K Current report
Regulation FD disclosure
May 29, 2026 May 29, 2026
8-K Current report
Regulation FD disclosure
May 26, 2026 May 26, 2026
8-K Current report
Regulation FD disclosure
May 22, 2026 May 22, 2026
8-K Current report
Results of operations
May 15, 2026 May 15, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure
May 13, 2026 May 13, 2026
8-K Current report
Regulation FD disclosure
May 12, 2026 May 12, 2026
8-K Current report
Regulation FD disclosure
May 8, 2026 May 8, 2026
8-K Current report
Regulation FD disclosure
Apr 23, 2026 Apr 23, 2026
8-K Current report
Shareholder vote results
Apr 15, 2026 Apr 15, 2026
EFFECT Filing Apr 14, 2026 —
10-K/A Amended annual report Apr 14, 2026 Dec 31, 2025
424B3 Prospectus Apr 14, 2026 —
CORRESP Letter to the SEC Apr 10, 2026 —
UPLOAD Letter from the SEC Apr 2, 2026 —
S-3 Shelf registration Mar 27, 2026 —
8-K Current report
Regulation FD disclosure
Mar 23, 2026 Mar 23, 2026
8-K Current report
Regulation FD disclosure
Mar 19, 2026 Mar 19, 2026
8-K Current report
Results of operations
Mar 19, 2026 Mar 19, 2026
10-K Annual report Mar 18, 2026 Dec 31, 2025
DEF 14A Proxy statement Mar 9, 2026 Apr 15, 2026
PRE 14A Preliminary proxy statement Feb 26, 2026 Apr 15, 2026
8-K Current report
Material agreement, Unregistered share sale
Feb 20, 2026 Feb 19, 2026
8-K Current report
Regulation FD disclosure
Feb 18, 2026 Feb 18, 2026
8-K Current report
Regulation FD disclosure
Feb 18, 2026 Feb 18, 2026
8-K Current report
Regulation FD disclosure
Feb 17, 2026 Feb 17, 2026
8-K Current report
Shareholder vote results
Feb 5, 2026 Feb 5, 2026
8-K Current report
Regulation FD disclosure
Jan 20, 2026 Jan 20, 2026
8-K Current report
Regulation FD disclosure
Jan 13, 2026 Jan 13, 2026
8-K Current report
Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
8-K Current report
Other events
Jan 7, 2026 Jan 7, 2026
EFFECT Filing Jan 6, 2026 —
DEF 14A Proxy statement Jan 2, 2026 Feb 5, 2026
CORRESP Letter to the SEC Jan 2, 2026 —
UPLOAD Letter from the SEC Jan 2, 2026 —
S-3 Shelf registration Dec 23, 2025 —
424B5 Prospectus supplement Dec 23, 2025 —
PRER14A Form prer14a Dec 22, 2025 —
8-K Current report
Material agreement, Other events
Dec 22, 2025 Dec 21, 2025
PRE 14A Preliminary proxy statement Dec 19, 2025 Feb 5, 2026
8-K Current report
Regulation FD disclosure
Dec 17, 2025 Dec 17, 2025
8-K Current report
Other events
Dec 16, 2025 Dec 15, 2025
8-K Current report
Material agreement, Unregistered share sale
Dec 10, 2025 Dec 9, 2025
8-K Current report
Regulation FD disclosure
Dec 9, 2025 Dec 9, 2025
8-K Current report
Regulation FD disclosure
Dec 8, 2025 Dec 8, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Nov 28, 2025 Nov 26, 2025
8-K Current report
Regulation FD disclosure
Nov 24, 2025 Nov 24, 2025
8-K Current report
Listing notice
Nov 21, 2025 Nov 20, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Regulation FD disclosure
Nov 13, 2025 Nov 13, 2025
8-K Current report
Regulation FD disclosure
Nov 12, 2025 Nov 12, 2025
8-K Current report
Regulation FD disclosure
Oct 30, 2025 Oct 30, 2025
8-K Current report
Regulation FD disclosure
Oct 29, 2025 Oct 29, 2025
8-K Current report
Regulation FD disclosure
Oct 23, 2025 Oct 23, 2025
8-K Current report
Shareholder vote results
Oct 16, 2025 Oct 16, 2025
424B3 Prospectus Oct 3, 2025 —
EFFECT Filing Sep 30, 2025 —
CORRESP Letter to the SEC Sep 29, 2025 —
8-K Current report
Regulation FD disclosure
Sep 25, 2025 Sep 25, 2025
UPLOAD Letter from the SEC Sep 24, 2025 —
S-3 Shelf registration Sep 19, 2025 —
DEF 14A Proxy statement Sep 15, 2025 Oct 16, 2025
S-8 Employee stock plan registration Sep 10, 2025 —
8-K Current report
Regulation FD disclosure
Sep 9, 2025 Sep 9, 2025
8-K Current report
Regulation FD disclosure
Sep 8, 2025 Sep 8, 2025
8-K Current report
Regulation FD disclosure
Sep 8, 2025 Sep 8, 2025
PRE 14A Preliminary proxy statement Sep 5, 2025 Oct 16, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 29, 2025 Aug 28, 2025
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Aug 27, 2025 Aug 21, 2025
8-K Current report
Regulation FD disclosure
Aug 18, 2025 Aug 18, 2025
8-K Current report
Shareholder vote results
Aug 18, 2025 Aug 18, 2025
8-K Current report
Results of operations
Aug 13, 2025 Aug 13, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Regulation FD disclosure
Aug 6, 2025 Aug 6, 2025
8-K Current report
Regulation FD disclosure
Aug 1, 2025 Aug 1, 2025
8-K Current report
Regulation FD disclosure
Jul 30, 2025 Jul 30, 2025
8-K Current report
Regulation FD disclosure
Jul 17, 2025 Jul 17, 2025
8-K Current report
Material agreement
Jul 11, 2025 Jul 11, 2025
424B5 Prospectus supplement Jul 11, 2025 —
8-K Current report
Regulation FD disclosure
Jul 9, 2025 Jul 9, 2025
DEFA14A Additional proxy material Jul 8, 2025 —
DEF 14A Proxy statement Jul 8, 2025 Aug 18, 2025
PRE 14A Preliminary proxy statement Jun 27, 2025 Aug 18, 2025
8-K Current report
Listing notice
Jun 27, 2025 Jun 27, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Jun 23, 2025 Jun 20, 2025
424B4 Prospectus Jun 23, 2025 —
EFFECT Filing Jun 20, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jun 18, 2025 Jun 18, 2025
CORRESP Letter to the SEC Jun 17, 2025 —
CORRESP Letter to the SEC Jun 17, 2025 —
CORRESP Letter to the SEC Jun 16, 2025 —
S-1/A Amended registration statement Jun 16, 2025 —
UPLOAD Letter from the SEC Jun 13, 2025 —
CORRESP Letter to the SEC Jun 11, 2025 —
S-1/A Amended registration statement Jun 11, 2025 —
UPLOAD Letter from the SEC Jun 10, 2025 —
S-1/A Amended registration statement Jun 6, 2025 —
8-K Current report
Regulation FD disclosure
Jun 5, 2025 Jun 5, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 4, 2025 Jun 4, 2025
CORRESP Letter to the SEC Jun 3, 2025 —
CORRESP Letter to the SEC Jun 3, 2025 —
S-1 Registration statement Jun 2, 2025 —
PRE 14A Preliminary proxy statement May 23, 2025 May 23, 2025
8-K Current report
Listing notice
May 23, 2025 May 23, 2025
DRS Filing May 23, 2025 —
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure
May 12, 2025 May 12, 2025
8-K Current report
Shareholder vote results
May 9, 2025 May 9, 2025
8-K Current report
Regulation FD disclosure
May 7, 2025 May 7, 2025
8-K Current report
Regulation FD disclosure
May 6, 2025 May 6, 2025
8-K Current report
Regulation FD disclosure
May 5, 2025 May 5, 2025
10-K/A Amended annual report Apr 30, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Apr 29, 2025 Apr 29, 2025
8-K Current report
Other events
Apr 25, 2025 Apr 25, 2025
8-K Current report
Regulation FD disclosure
Apr 21, 2025 Apr 21, 2025
10-K/A Amended annual report Apr 18, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure
Apr 17, 2025 Apr 17, 2025
8-K Current report
Other events
Apr 9, 2025 Apr 9, 2025
EFFECT Filing Apr 7, 2025 —
CORRESP Letter to the SEC Apr 4, 2025 —
UPLOAD Letter from the SEC Apr 4, 2025 —
8-K Current report
Regulation FD disclosure
Apr 1, 2025 Apr 1, 2025
S-1 Registration statement Mar 31, 2025 —
8-K Current report
Regulation FD disclosure
Mar 24, 2025 Mar 24, 2025
8-K Current report
Results of operations
Mar 24, 2025 Mar 24, 2025
10-K Annual report Mar 21, 2025 Dec 31, 2024
DEF 14A Proxy statement Mar 13, 2025 Apr 9, 2025
8-K Current report
Regulation FD disclosure
Mar 6, 2025 Mar 6, 2025
PRE 14A Preliminary proxy statement Mar 3, 2025 Apr 9, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 26, 2025 Feb 25, 2025
424B5 Prospectus supplement Feb 26, 2025 —
RW Form rw Feb 24, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Feb 13, 2025 Feb 13, 2025
8-K Current report
Regulation FD disclosure
Feb 13, 2025 Feb 13, 2025
8-K Current report
Regulation FD disclosure
Feb 11, 2025 Feb 11, 2025
S-1/A Amended registration statement Feb 11, 2025 —
8-K Current report
Material agreement
Feb 10, 2025 Feb 9, 2025
S-1/A Amended registration statement Feb 10, 2025 —
S-1/A Amended registration statement Jan 29, 2025 —
8-K/A Amended current report
Regulation FD disclosure
Jan 27, 2025 Jan 27, 2025
8-K Current report
Regulation FD disclosure
Jan 27, 2025 Jan 27, 2025
8-K Current report
Regulation FD disclosure
Jan 27, 2025 Jan 27, 2025
8-K Current report
Regulation FD disclosure
Jan 8, 2025 Jan 8, 2025
8-K Current report
Regulation FD disclosure
Jan 8, 2025 Jan 8, 2025
8-K Current report
Regulation FD disclosure
Dec 18, 2024 Dec 18, 2024
S-1 Registration statement Dec 13, 2024 —
8-K Current report
Regulation FD disclosure
Dec 11, 2024 Dec 11, 2024
EFFECT Filing Dec 9, 2024 —
POS AM Form pos am Dec 3, 2024 —
8-K Current report
Regulation FD disclosure
Nov 18, 2024 Nov 18, 2024
8-K Current report
Regulation FD disclosure
Nov 18, 2024 Nov 18, 2024
8-K Current report
Regulation FD disclosure
Nov 14, 2024 Nov 14, 2024
8-K Current report
Regulation FD disclosure
Nov 14, 2024 Nov 14, 2024
8-K Current report
Regulation FD disclosure
Nov 12, 2024 Nov 12, 2024
8-K Current report
Regulation FD disclosure
Nov 12, 2024 Nov 12, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 11, 2024
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Regulation FD disclosure
Nov 5, 2024 Nov 5, 2024
S-8 Employee stock plan registration Oct 25, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Oct 25, 2024 Oct 24, 2024
8-K Current report
Regulation FD disclosure
Oct 17, 2024 Oct 17, 2024
8-K Current report
Regulation FD disclosure
Oct 7, 2024 Oct 7, 2024
8-K Current report
Regulation FD disclosure
Oct 2, 2024 Oct 2, 2024
8-K Current report
Regulation FD disclosure
Sep 23, 2024 Sep 23, 2024
8-K Current report
Regulation FD disclosure
Sep 16, 2024 Sep 16, 2024
8-K Current report
Regulation FD disclosure
Sep 16, 2024 Sep 16, 2024
DEFA14A Additional proxy material Sep 13, 2024 —
DEF 14A Proxy statement Sep 13, 2024 Oct 24, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MBRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Houston, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1659617

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.